News Image

Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q2 2025 Earnings: Revenue Miss but Narrower Loss and Clinical Progress Boost Shares

By Mill Chart

Last update: Jul 30, 2025

Wave Life Sciences Ltd (NASDAQ:WVE) reported its second-quarter 2025 financial results, missing analyst revenue estimates but showing a narrower-than-expected loss per share. The company posted revenue of $8.7 million, falling short of the consensus estimate of $11.42 million. Meanwhile, its reported loss per share of $0.31 was slightly better than the anticipated $0.29 loss.

Key Financial Takeaways

  • Revenue Miss: Actual revenue of $8.7M vs. $11.42M estimated (23.8% below expectations).
  • EPS Beat: Reported loss of $0.31 per share vs. estimated loss of $0.29.
  • Market Reaction: The stock is up ~2.64% in pre-market trading, suggesting investor optimism despite the revenue shortfall.

Business Update Highlights

The company highlighted progress in its RestorAATion-2 study for WVE-006, its leading RNA-editing candidate targeting Alpha-1 antitrypsin deficiency (AATD). Key developments include:

  • Completion of multi-dosing in the first cohort (200 mg).
  • Single-dosing completed in the second cohort (400 mg).
  • The drug aims to address both lung and liver complications of AATD, positioning it as a potential breakthrough therapy.

Market Sentiment & Outlook

The pre-market uptick indicates that investors may be focusing more on the clinical progress rather than the revenue miss. With no explicit financial guidance provided in the press release, the market reaction appears driven by optimism around WVE-006’s advancement.

Analyst estimates for Q3 2025 project a loss of $0.27 per share on $12.79 million in revenue, while full-year 2025 expectations stand at a $1.08 loss per share with $59.35 million in sales.

For a deeper dive into Wave Life Sciences’ earnings and future estimates, review the full earnings breakdown here.

Disclaimer: This article is not financial advice. Investors should conduct their own research or consult a financial advisor before making investment decisions.

WAVE LIFE SCIENCES LTD

NASDAQ:WVE (7/29/2025, 8:00:02 PM)

Premarket: 8.54 +0.22 (+2.64%)

8.32

+0.14 (+1.71%)



Find more stocks in the Stock Screener

WVE Latest News and Analysis

Follow ChartMill for more